I showed deaths going up at a slower rate than cases were going up, even allowing for the lag, and questioned if that were due to younger people getting infected, better treatment, or a mutation making the virus less pathogenic. Or all of the above. Nobody could find good enough figures to do analysis of variance and tease the actual attributable risk and improvement of treatment effectiveness out, although it was clear that the infected were trending younger.

So, I guess you couldn’t come up with a pertinent comment regarding the state deathrate issue, huh?